Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Using psychological treatments can help manage skin conditions along with regular medical care.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Some alternative treatments for hair loss might work, but more research is needed.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

People undergoing chemotherapy need better support and information to cope with hair loss.